More recently, the FDA posted two two letters: one backdated for September 9, regarding GSK’s HIV medication Apretude and one ...

FDA clears first gene therapy for rare disease; Roche’s breast cancer pill win; Women increasingly turn to GLP-1s.

Citius Oncology entered into an exclusive distribution agreement with Er-Kim to expand international access to Lymphir (denileukin diftitox-cxdl) in Turkey, Bahrain, Qatar, Oman, Kuwait, Saudi Arabia ...

Sam Glassenberg, EVP of Relevate Health Games, launched this session at the AI Deciphered conference by pointing out how wholeheartedly the video game industry has embraced generative AI. Indeed, the ...

In 2026, the Trump administration will require U.S. cancer registries that receive federal funding to classify patients’ sex as male, female — or not stated/unknown.

Myles, who previously worked at National Institutes of Health, shared how the new administration has impacted the federal agency’s communications.

Totalling $25 billion higher than Netflix’s bid, analysts say whichever company ultimately secures WBD will gain a decisive advantage in the streaming wars.

Fresh insights from SiriusXM Media’s 2026 pharma audience research study reveal a clear shift in how and where pharma consumers want to hear from Rx brands today.

Despite new rules that went into effect in mid-2024 aimed at thwarting such unauthorized ACA changes, it’s still happening.

Havas Health and Creative Networks hired Harriet Flory as global chief communications officer, reporting to global CEO Donna Murphy. Havas Health Network appointed Chinkara Singh as chief production ...